We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

194 hedge funds and large institutions have $2.05B invested in Beam Therapeutics in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 78 increasing their positions, 47 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $16M | Put options by funds: $6.86M

66% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 47

11% more capital invested

Capital invested by funds: $1.85B → $2.05B (+$201M)

0.84% more ownership

Funds ownership: 83.39% → 84.24% (+0.84%)

6% less funds holding

Funds holding: 206 → 194 (-12)

35% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 31

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
194
Holders Change
-12
Holders Change %
-5.83%
% of All Funds
3.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
20
Increased
78
Reduced
47
Closed
31
Calls
$16M
Puts
$6.86M
Net Calls
+$9.17M
Net Calls Change
+$16.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$34.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$34.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$20.3M
4
NAMA
Nikko Asset Management Americas
New York
+$18.1M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$18.1M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$15.1M
2
Bank of America
Bank of America
North Carolina
-$6.47M
3
AIM
ARK Investment Management
Florida
-$6.19M
4
EC
EcoR1 Capital
California
-$6.08M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
26
Eventide Asset Management
Massachusetts
$14.7M – – –
AI
27
Alphabet Inc
California
$10.3M – – –
Citadel Advisors
28
Citadel Advisors
Florida
$10.2M +$4.49M +138,344 +76%
Norges Bank
29
Norges Bank
Norway
$9.85M -$2.78M -85,629 -22%
Mirae Asset Global Investments
30
Mirae Asset Global Investments
South Korea
$9.41M +$2.2M +67,819 +30%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$9.09M +$3.38M +104,255 +58%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$8.24M +$1.5M +46,323 +22%
HRCM
33
Hood River Capital Management
Florida
$8.04M +$455K +14,026 +6%
UBS AM
34
UBS AM
Illinois
$7.23M – – –
Millennium Management
35
Millennium Management
New York
$6.24M +$82.1K +2,531 +1%
JFG
36
Jefferies Financial Group
New York
$6.23M +$6.33M +195,000 New
Bank of America
37
Bank of America
North Carolina
$5.69M -$6.47M -199,334 -53%
N
38
Nuveen
North Carolina
$5.46M -$975K -30,057 -15%
Citigroup
39
Citigroup
New York
$5.19M -$1.84M -56,847 -26%
Schroder Investment Management Group
40
Schroder Investment Management Group
United Kingdom
$4.99M -$3.33M -102,538 -40%
Barclays
41
Barclays
United Kingdom
$4.61M +$938K +28,903 +25%
Jane Street
42
Jane Street
New York
$4.26M +$2.99M +92,210 +224%
CS
43
Candriam SCA
Luxembourg
$4.14M +$1.62M +50,000 +63%
UBS Group
44
UBS Group
Switzerland
$4.06M +$2.4M +73,921 +139%
Swiss National Bank
45
Swiss National Bank
Switzerland
$4.03M +$143K +4,400 +4%
Russell Investments Group
46
Russell Investments Group
United Kingdom
$3.72M +$247K +7,602 +7%
CIM
47
Contrarius Investment Management
Jersey
$3.62M +$3.68M +113,364 New
RSCM
48
Rock Springs Capital Management
Maryland
$3.56M – – –
GGHC
49
Gilder Gagnon Howe & Co
New York
$3.44M -$3.21K -99 -0.1%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$3.21M – – –
1
2
3 4 5

BEAM Hedge Fund Activity: Q2 2023 in Review

194 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2023, worth a combined $2.05B — up 11% from $1.85B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of BEAM and 20 opened new positions — a net loss of 11 holders — while 47 trimmed existing stakes and 78 added.

The largest buyer was BlackRock, adding an estimated $34.4M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $15.1M sold.

  • 194 institutional investors held Beam Therapeutics (BEAM) as of Q2 2023, down from 206 in Q1 2023.
  • Funds reported $2.05B of Beam Therapeutics stock for Q2 2023, up 11% quarter-over-quarter.
  • 20 funds opened new Beam Therapeutics positions in Q2 2023 and 31 closed out, a net change of -11 holders.
  • The largest Beam Therapeutics buyer in Q2 2023 was BlackRock, an estimated $34.4M added.
  • The largest Beam Therapeutics seller in Q2 2023 was Capital Research Global Investors, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2023.